• WORK
  • BIO
  • GUT
  • CONTACT

MIKE ABADI

Associate Creative Director/Writer

  • WORK
  • BIO
  • GUT
  • CONTACT

UNUM

Employers needed to know that poor health benefits could affect the well being of their bottom line.

 

EFFEXOR XR 

To educate those suffering from social anxiety, we aimed to lessen the stigma of the condition.

 

EFFEXOR: HCP Mailer

Effexor is an antidepressant with a very high rate of patients achieving remission of symptoms. This kicked off a campaign which alerted physicians that patients taking Effexor had a greater chance of enjoying the simple things in life. 

 

Consumer brochure

Some patients believe their mental state is fine when it's really sub-par. This mailer is a wake-up call saying they could get back to their old life. It came with a brief questionnaire to help them determine if their symptoms are worth a trip to the doctor.

EFF+_Depression1.jpg
EFF_Depression2.jpg
EFF_DepressoinInsert.jpg
EFF+_Depression1.jpg EFF_Depression2.jpg EFF_DepressoinInsert.jpg

CD Mailer to Physicians

Employing the words of a medical thought leader, we told physicians that having patients respond to medication was only a start. The enclosed CD detailed how Effexor helped patients go beyond that first benchmark and achieve remission.

 

Detail Aid

Leveraging an array of compelling charts, graphs, and other scientific data, this comprehensive sales aid told Effexor's remission story by touting its proven performance and superb outcomes.

EffexorDetailAid_Cover.jpg
EffexorDetailAid_Popout1.jpg
EffexorDetailAid_Spread1.jpg
EffexorDetailAid_Spread2.jpg
EffexorDetailAid_Spread3 (1).jpg
EffexorDetailAid_Spread4 (1).jpg
EffexorDetailAid_TheBackCover (1).jpg
EffexorDetailAid_Cover.jpg EffexorDetailAid_Popout1.jpg EffexorDetailAid_Spread1.jpg EffexorDetailAid_Spread2.jpg EffexorDetailAid_Spread3 (1).jpg EffexorDetailAid_Spread4 (1).jpg EffexorDetailAid_TheBackCover (1).jpg
 

UNBRANDED DIABETIC RETINOPATHY DRUG (PITCH)

To educate diabetic patients and their caregivers about this debilitating eye condition, we recommended Experiential, Instagram, YouTube, and Out-of-Home advertising.

EYLEA UNBRANDED 5.3_Page_01.jpg
EYLEA UNBRANDED 5.3_Page_02.jpg
EYLEA UNBRANDED 5.3_Page_03.jpg
EYLEA UNBRANDED 5.3_Page_04.jpg
EYLEA UNBRANDED 5.3_Page_05.jpg
EYLEA UNBRANDED 5.3_Page_06.jpg
EYLEA UNBRANDED 5.3_Page_07.jpg
EYLEA UNBRANDED 5.3_Page_08.jpg
EYLEA UNBRANDED 5.3_Page_09.jpg
EYLEA UNBRANDED 5.3_Page_10.jpg
EYLEA UNBRANDED 5.3_Page_11.jpg
EYLEA UNBRANDED 5.3_Page_01.jpg EYLEA UNBRANDED 5.3_Page_02.jpg EYLEA UNBRANDED 5.3_Page_03.jpg EYLEA UNBRANDED 5.3_Page_04.jpg EYLEA UNBRANDED 5.3_Page_05.jpg EYLEA UNBRANDED 5.3_Page_06.jpg EYLEA UNBRANDED 5.3_Page_07.jpg EYLEA UNBRANDED 5.3_Page_08.jpg EYLEA UNBRANDED 5.3_Page_09.jpg EYLEA UNBRANDED 5.3_Page_10.jpg EYLEA UNBRANDED 5.3_Page_11.jpg
 

OXFORD

A mailer that shows New Yorkers more paths to affordable healthcare.

oxford-sub-cov.jpg
oxford-sub-spread-1.jpg
oxford-sub-spread-2.jpg
oxford-sub-spread-3.jpg
oxford-sub-spread-4.jpg
oxford-sub-cov.jpg oxford-sub-spread-1.jpg oxford-sub-spread-2.jpg oxford-sub-spread-3.jpg oxford-sub-spread-4.jpg